Table 1 Clinical characteristics of the patients
From: Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Treated (n = 12) | Not treated (n = 10) | |
|---|---|---|
Age (years) [median; min–max] | 12.2; 8–16 | 11.5; 7–16 |
BMI [median; min–max] | 17.1; 12.5–23.5 | 16.7; 14.2–20.8 |
Polydipsia at diagnosis (number of patients) | 5 | 8 |
Polyuria at diagnosis (number of patients) | 5 | 3 |
Loss of weight at diagnosis (number of patients) | 4 | 3 |
pH at diagnosis (capillary blood) [median; min–max] | 7.40; 7.36–7.42 | 7.39; 7.35–7.53 |
pO2 at diagnosis (capillary blood—mmHg) [median; min–max] | 69.3; 24.1–88.0 | 69.5; 56.0–86.6 |
pCO2 at diagnosis (capillary blood—mmHg) [median; min–max] | 39.6; 28.0–46.9 | 38.0; 24.0–40.7 |
HCO3 at diagnosis (capillary blood—mmHg) [median; min–max] | 24.15; 18.8–27.4 | 23.6; 21.3–25.2 |
Acid/base balance at diagnosis (BE—mEq/l) [median; min–max] | 0.05; −7.8–3.2 | −0.5; −3.8–0.9 |
Sat02 at diagnosis (capillary blood—%) [median; min–max] | 94.1; 90.2–97.3 | 95.4; 92.4–97.2 |
Anti-GAD65 antibody (number of patients) | 9 | 9 |
ICA (number of patients) | 7 | 5 |
IAA (number of patients) | 7 | 4 |